Hoffmann-La Roche Ltd, Horiba Ltd., Neomedica, Thermo Fisher Scientific, Agilent, and several others, are currently operating ...

Research at the annual meeting of the American Society of Hematology evaluated patient and caregiver perspectives on gene ...

A pair of studies presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition highlight continuing ...

STAT reporters discuss why drugmakers have not lobbied against RFK Jr.'s nomination to lead HHS and the struggles around ...

For patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (ALL) with an average or high risk for ...

Data from the Phase I/II TRANSCEND CLL 004 study evaluating the combination of Bristol Myers Squibb’s (BMS’s) Breyanzi ...

Long-term exposure to air pollution poses an increased risk of blood clots in deep veins, which can result in serious ...

The hematology market is experiencing significant growth driven by the increasing prevalence of blood-related disorders, advancements in research and product development, and the rising number ...

I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of ...

Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...

In a report released on December 10, Mitchell Kapoor from H.C. Wainwright maintained a Buy rating on Metagenomi, Inc. (MGX – Research Report), ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...